Pharmaceuticals in Germany

Pharmaceuticals

Publication Date	April 2009
Publisher	Datamonitor
Product Type	Report
Pages	37
ISBN Number	not applicable
Product Code	DAT03038

Buy this product or for assistance call +44 20 7060 7474

PDF £150.00$250 | €168

FAX Order above formats by FAX

Summary

Datamonitor's Pharmaceuticals in Germany industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

Contains an executive summary and data on value, volume and/or segmentation
Provides textual analysis of the industry's recent performance and future prospects
Incorporates in-depth five forces competitive environment analysis and scorecards
Includes a five-year forecast of the industry
The leading companies are profiled with supporting key financial metrics
Supported by the key macroeconomic and demographic data affecting the market

Highlights

Detailed information is included on market size, measured by value and/or volume
Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
Market shares are covered by manufacturer or brand

Why you should buy this report

Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2007 annual average exchange rates.

The global figure comprises the Americas, Asia-Pacific and Europe.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Content

EXECUTIVE SUMMARY
Chapter 1 Market Overview
- 1.1 Market Definition
- 1.2 Research Highlights
- 1.3 Market Analysis
Chapter 2 Market Value
CHAPTER 3 Market Segmentation I
CHAPTER 4 Market Segmentation II
Chapter 5 Market Share
Chapter 6 Five Forces Analysis
- 6.1 Summary
- 6.2 Buyer Power
- 6.3 Supplier Power
- 6.4 New Entrants
- 6.5 Substitutes
- 6.6 Rivalry
Chapter 7 Leading Companies
- 7.1 Sanofi-Aventis SA
- 7.2 Novartis AG
- 7.3 Pfizer Inc
- 7.4 AstraZeneca PLC
Chapter 8 Market Forecasts
- 8.1 Market Value Forecast
Chapter 9 Macroeconomic Indicators
Chapter 10 Appendix
- 10.1 Methodology
- 10.2 Industry Associations
- 10.3 Related Datamonitor Research
LIST OF TABLES
- Table 1: Germany Pharmaceuticals Market Value: $ billion, 2004-2008
- Table 2: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e)
- Table 3: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e)
- Table 4: Germany Pharmaceuticals Market Share: % Share, by Value, 2008(e)
- Table 1: Key Facts: Sanofi-Aventis SA
- Table 2: Key Financials: Sanofi-Aventis SA
- Table 3: Key Facts: Novartis AG
- Table 4: Key Financials: Novartis AG
- Table 5: Key Facts: Pfizer Inc
- Table 6: Key Financials: Pfizer Inc
- Table 7: Key Facts: AstraZeneca PLC
- Table 8: Key Financials: AstraZeneca PLC
- Table 9: Germany Pharmaceuticals Market Value Forecast: $ billion, 2008-2013
- Table 10: Germany Size of Population (million) , 2004-2008
- Table 11: Germany GDP (Constant 2000 Prices, $ billion), 2004-2008
- Table 12: Germany Inflation, 2004-2008
- Table 13: Germany Exchange Rate, 2004-2008